PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
BEAM vs. TWST
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between BEAM and TWST is 0.59, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.00.6

Performance

BEAM vs. TWST - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Beam Therapeutics Inc. (BEAM) and Twist Bioscience Corporation (TWST). The values are adjusted to include any dividend payments, if applicable.

20.00%40.00%60.00%80.00%JulyAugustSeptemberOctoberNovemberDecember
41.81%
54.82%
BEAM
TWST

Key characteristics

Sharpe Ratio

BEAM:

-0.12

TWST:

0.37

Sortino Ratio

BEAM:

0.38

TWST:

1.08

Omega Ratio

BEAM:

1.04

TWST:

1.12

Calmar Ratio

BEAM:

-0.10

TWST:

0.30

Martin Ratio

BEAM:

-0.22

TWST:

1.39

Ulcer Index

BEAM:

38.95%

TWST:

18.69%

Daily Std Dev

BEAM:

73.19%

TWST:

69.82%

Max Drawdown

BEAM:

-86.76%

TWST:

-94.48%

Current Drawdown

BEAM:

-80.10%

TWST:

-76.84%

Fundamentals

Market Cap

BEAM:

$2.20B

TWST:

$2.86B

EPS

BEAM:

-$1.58

TWST:

-$3.60

Total Revenue (TTM)

BEAM:

$349.64M

TWST:

$312.97M

Gross Profit (TTM)

BEAM:

$327.80M

TWST:

$133.35M

EBITDA (TTM)

BEAM:

-$160.83M

TWST:

-$176.71M

Returns By Period

In the year-to-date period, BEAM achieves a -2.31% return, which is significantly lower than TWST's 30.67% return.


BEAM

YTD

-2.31%

1M

-2.24%

6M

13.49%

1Y

-9.65%

5Y*

N/A

10Y*

N/A

TWST

YTD

30.67%

1M

-0.32%

6M

-2.26%

1Y

26.15%

5Y*

16.95%

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

BEAM vs. TWST - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Beam Therapeutics Inc. (BEAM) and Twist Bioscience Corporation (TWST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for BEAM, currently valued at -0.12, compared to the broader market-4.00-2.000.002.00-0.120.37
The chart of Sortino ratio for BEAM, currently valued at 0.38, compared to the broader market-4.00-2.000.002.004.000.381.08
The chart of Omega ratio for BEAM, currently valued at 1.04, compared to the broader market0.501.001.502.001.041.12
The chart of Calmar ratio for BEAM, currently valued at -0.10, compared to the broader market0.002.004.006.00-0.100.30
The chart of Martin ratio for BEAM, currently valued at -0.22, compared to the broader market0.005.0010.0015.0020.0025.00-0.221.39
BEAM
TWST

The current BEAM Sharpe Ratio is -0.12, which is lower than the TWST Sharpe Ratio of 0.37. The chart below compares the historical Sharpe Ratios of BEAM and TWST, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00JulyAugustSeptemberOctoberNovemberDecember
-0.12
0.37
BEAM
TWST

Dividends

BEAM vs. TWST - Dividend Comparison

Neither BEAM nor TWST has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

BEAM vs. TWST - Drawdown Comparison

The maximum BEAM drawdown since its inception was -86.76%, smaller than the maximum TWST drawdown of -94.48%. Use the drawdown chart below to compare losses from any high point for BEAM and TWST. For additional features, visit the drawdowns tool.


-84.00%-82.00%-80.00%-78.00%-76.00%-74.00%-72.00%JulyAugustSeptemberOctoberNovemberDecember
-80.10%
-76.84%
BEAM
TWST

Volatility

BEAM vs. TWST - Volatility Comparison

Beam Therapeutics Inc. (BEAM) has a higher volatility of 22.11% compared to Twist Bioscience Corporation (TWST) at 17.08%. This indicates that BEAM's price experiences larger fluctuations and is considered to be riskier than TWST based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%25.00%JulyAugustSeptemberOctoberNovemberDecember
22.11%
17.08%
BEAM
TWST

Financials

BEAM vs. TWST - Financials Comparison

This section allows you to compare key financial metrics between Beam Therapeutics Inc. and Twist Bioscience Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab